Traws Pharma (formerly Onconova) Granted European Patent EP4193988 For Solid Tumor Cancer Treatment Method
Portfolio Pulse from Benzinga Newsdesk
Traws Pharma, formerly known as Onconova, has been granted European Patent EP4193988 for a method of treating solid tumor cancers.
June 05, 2024 | 3:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Traws Pharma has been granted a European patent for a method of treating solid tumor cancers, which could enhance its market position and future revenue potential.
The granting of a European patent for a solid tumor cancer treatment method is a significant milestone for Traws Pharma. This could lead to increased market share and revenue as the company can now protect its intellectual property in Europe, potentially attracting more investors and partnerships.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100